Editorial Acesso aberto

Evolution and transformation of JVS-VL

2021; Elsevier BV; Volume: 10; Issue: 1 Linguagem: Inglês

10.1016/j.jvsv.2021.11.001

ISSN

2213-3348

Autores

Péter Gloviczki, Peter F. Lawrence,

Tópico(s)

Peripheral Artery Disease Management

Resumo

Don't stress on what was, fight for what could be.—Sean Higgins As 2021 comes to an end, we are pleased to report that the state of the Journal of Vascular Surgery Publications is stronger than at any time in the history of our journals. This was a year of growth and transformation. The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) reinforced its position as the leading publication in the international venous and lymphatic field with an Impact Factor of 2.859 in the 9th year of its publication, and the Journal of Vascular Surgery (JVS) earned an Impact Factor of 4.268, an all-time high in the 38-year existence of this premier international publication. The Journal of Vascular Surgery Cases, Innovations and Techniques has been growing rapidly, publishing an estimated 33% more articles this year than just 2 years ago. We adjusted the name to indicate the increased the scope of this open access, online journal; we now accept articles on innovations in practice, education, outcome assessment, and techniques, in addition to case reports, vascular videos and images. The fourth member of the JVS family, JVS-Vascular Science (JVS-VS), has also grown well beyond expectations. Recognizing the high scientific and editorial standards of this journal, the U.S. National Library of Medicine just accepted JVS-VS into PubMed Central, so all articles will be indexed retroactively starting with Volume 1, 2020. Quite an accomplishment from a young journal in its 2nd year of publication. This welcome evolution of a high-quality JVS portfolio occurred in parallel with major transformations of our editorial policies, educational programs, leadership, and boards, as the diversity of each journal’s editorial board has significantly improved and now includes ≥25% women and under-represented minorities. The second year of the COVID-19 pandemic that has claimed over 700,000 lives in the United States has had a sustained effect on all scientific publications, including the JVS journals. Submission rates of all categories of articles remained extremely high, with an estimated 2859 new submissions in 2021, 31% higher than before the pandemic and just slightly lower than in 2020. In addition, this year we published ∼70 articles on COVID-19 and vascular disease, and our online collection includes 152 articles (www.jvsvenous.org). The JVS-VL, or the “blue” venous and lymphatic journal in our portfolio, is a hybrid subscription and open access bimonthly publication, with a print circulation of 2857, an estimated 78,000 full-text downloads, and 6500 average monthly visits in 2021 to our website, www.jvsvenous.org. With the high volume of cited references, website visits, and paper downloads, JVS-VL continues to be the premier international journal of medical, endovascular, and surgical care of venous and lymphatic disorders, publishing articles from 33 countries. Among venous journals, we lead the way in Impact Factor, total citations, number of citable articles, the SCImago Journal Rank, and the Immediacy Index, which counts citations in the year of publication (Table I).1Obi A.T. Tignanelli C.J. Jacobs B.N. Arya S. Wakefield T.W. Henke P.K. et al.Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.J Vasc Surg Venous Lymphat Disord. 2019; 7: 317-324Abstract Full Text Full Text PDF PubMed Scopus (99) Google Scholar, 2Rossi F.H. Kambara A.M. Izukawa N.M. Rodrigues T.O. Rossi C.B. Sousa A.G. et al.Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease.J Vasc Surg Venous Lymphat Disord. 2018; 6: 183-191Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 3Gibson K. Morrison N. Kolluri R. Vasquez M. Weiss R. Cher D. et al.Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins.J Vasc Surg Venous Lymphat Disord. 2018; 6: 606-613Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 4Gagne P.J. Gasparis A. Black S. Thorpe P. Passman M. Vedantham S. et al.Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial.J Vasc Surg Venous Lymphat Disord. 2018; 6: 48-56.e1Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 5Kheirelseid E.A.H. Crowe G. Sehgal R. Liakopoulos D. Bela H. Mulkern E. et al.Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins.J Vasc Surg Venous Lymphat Disord. 2018; 6: 256-270Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar, 6Holewijn S. van Eekeren R.R.J.P. Vahl A. de Vries J.P.P.M. Reijnen M.M.P.J. Werson D. et al.Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial).J Vasc Surg Venous Lymphat Disord. 2019; 7: 364-374Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar, 7Avgerinos E.D. Saadeddin Z. Abou Ali A.N. Fish L. Toma C. Chaer M. et al.A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.J Vasc Surg Venous Lymphat Disord. 2018; 6: 530-540Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar, 8Razavi M. Marston W. Black S. Bentley D. Neglen P. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction.J Vasc Surg Venous Lymphat Disord. 2018; 6: 192-200Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 9Velasquez C.A. Saeyeldin A. Zafar M.A. Brownstein A.J. Erben Y. A systematic review on management of nutcracker syndrome.J Vasc Surg Venous Lymphat Disord. 2018; 6: 271-278Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar, 10Ayad M.T. Gillespie D.L. Long-term complications of inferior vena cava filters.J Vasc Surg Venous Lymphat Disord. 2019; 7: 139-144Abstract Full Text Full Text PDF PubMed Scopus (25) Google ScholarTable ITop 10 cited articles in 2020 published in 2018-2019.1Obi A.T. Tignanelli C.J. Jacobs B.N. Arya S. Wakefield T.W. Henke P.K. et al.Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.J Vasc Surg Venous Lymphat Disord. 2019; 7: 317-324Abstract Full Text Full Text PDF PubMed Scopus (99) Google Scholar, 2Rossi F.H. Kambara A.M. Izukawa N.M. Rodrigues T.O. Rossi C.B. Sousa A.G. et al.Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease.J Vasc Surg Venous Lymphat Disord. 2018; 6: 183-191Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 3Gibson K. Morrison N. Kolluri R. Vasquez M. Weiss R. Cher D. et al.Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins.J Vasc Surg Venous Lymphat Disord. 2018; 6: 606-613Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 4Gagne P.J. Gasparis A. Black S. Thorpe P. Passman M. Vedantham S. et al.Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial.J Vasc Surg Venous Lymphat Disord. 2018; 6: 48-56.e1Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 5Kheirelseid E.A.H. Crowe G. Sehgal R. Liakopoulos D. Bela H. Mulkern E. et al.Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins.J Vasc Surg Venous Lymphat Disord. 2018; 6: 256-270Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar, 6Holewijn S. van Eekeren R.R.J.P. Vahl A. de Vries J.P.P.M. Reijnen M.M.P.J. Werson D. et al.Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial).J Vasc Surg Venous Lymphat Disord. 2019; 7: 364-374Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar, 7Avgerinos E.D. Saadeddin Z. Abou Ali A.N. Fish L. Toma C. Chaer M. et al.A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.J Vasc Surg Venous Lymphat Disord. 2018; 6: 530-540Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar, 8Razavi M. Marston W. Black S. Bentley D. Neglen P. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction.J Vasc Surg Venous Lymphat Disord. 2018; 6: 192-200Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 9Velasquez C.A. Saeyeldin A. Zafar M.A. Brownstein A.J. Erben Y. A systematic review on management of nutcracker syndrome.J Vasc Surg Venous Lymphat Disord. 2018; 6: 271-278Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar, 10Ayad M.T. Gillespie D.L. Long-term complications of inferior vena cava filters.J Vasc Surg Venous Lymphat Disord. 2019; 7: 139-144Abstract Full Text Full Text PDF PubMed Scopus (25) Google ScholarPublication yearDocument titleAuthorsVolumeIssue2020 CitesAll cites2019Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patientsObi A.T., Tignanelli C.J., Jacobs B.N., Arya S., Park P.K., Wakefield T.W., Henke P.K., Napolitano L.M.7344902018Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous diseaseRossi F.H., Kambara A.M., Izukawa N.M., Rodrigues T.O., Rossi C.B., Sousa A.G., Metzger P.B., Thorpe P.E.6215392018Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veinsGibson K., Morrison N., Kolluri R., Vasquez M., Weiss R., Cher D., Madsen M., Jones A.6514322018Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trialGagne P.J., Gasparis A., Black S., Thorpe P., Passman M., Vedantham S., Marston W., Iafrati M.6112492018Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veinsKheirelseid E.A.H., Crowe G., Sehgal R., Liakopoulos D., Bela H., Mulkern E., McDonnell C., O'Donohoe M.6212322019Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial)Holewijn S., van Eekeren R.R.J.P., Vahl A., de Vries J.P.P.M., Reijnen M.M.P.J., Werson D., Cuijpers-Patist B., Boersma D., Bosma J., Kolkert J.L.P., Leijdekkers V.J., Minnee R.C., van Nieuwenhuizen R.C., van 't Sant H.P., van Sterkenburg S., Smeets L., Lardenoije J.7311212018A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolismAvgerinos E.D., Saadeddin Z., Abou Ali A.N., Fish L., Toma C., Chaer M., Rivera-Lebron B.N., Chaer R.A.6410262018The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstructionRazavi M., Marston W., Black S., Bentley D., Neglen P.629282018A systematic review on management of nutcracker syndromeVelasquez C.A., Saeyeldin A., Zafar M.A., Brownstein A.J., Erben Y.629232019Long-term complications of inferior vena cava filtersAyad M.T., Gillespie D.L.71921 Open table in a new tab Social media continues to be an important tool for JVS Journal Editors, authors, and readers. JVS has 4513 Facebook, 7037 Twitter, and 16,861 LinkedIn followers. Our social media channels regularly promote our Special Features, that include the monthly Editors' Choice summary videos, the ever-popular Video Abstracts, Press Releases, Audible Bleeding podcasts, Journal Clubs, special journal events, and more. We are pleased to see that JVS-VL content usage continues to grow and hope that the progress in the journal quality metrics, as well as the increasing social media presence, translate into a better understanding of venous disease by vascular specialists and into better care and outcomes for all vascular patients, which is our ultimate goal. 2021 was the year of major transformations in our educational programs. The JVS Journal Club, now held monthly and spearheaded by Paul DiMuzio and Misty Humphries, has had dedicated followers since its inception, with 100 to 150 trainees and practicing vascular specialists signed up for each event. The quality has been exceptional, the discussions have been lively and engaging, and we anticipate it will continue to prosper. The journal club represents a great way to read and understand papers published in all JVS journals, including JVS-VL. Ulka Sachdev-Ost, our new Associate Editor with a focus on Diversity, Equity, and Inclusion (DEI), developed the JVS internship to teach residents and fellows about the process of reviewing vascular papers. Our goal with this educational program was both training the next generation of reviewers as well as improving their clinical and basic research skills. We have seven interns, and each has a mentor who works with them closely in reviewing papers and making suggestions for improvement. Interns also attend monthly presentations by the JVS faculty. These sessions will be available online in the new SVS learning system. Our collaboration with Audible Bleeding, a podcast recorded on JVS-VL, deserves special recognition. The discussion of four highlighted papers of each issue has opened the journal to those who use podcasts to keep current on venous publications, often while carrying very busy schedules as residents and fellows. Thanks to Nicole Rich, Adham Elmously, Adam Johnson, Sharif Ellozy, Jacob Schwartzman, and other founders and collaborators of Audible Bleeding who have created a great learning tool for our journal. In 2021, JVS-VL published many excellent articles, including two important multi-society documents. The first appeared in the January 2021 issue of JVS-VL, was an update of the classification and treatment of endothermal heat-induced thrombosis, with recommendations from the American Venous Forum and the Society for Vascular Surgery, authored by Kabnick and colleagues.11Kabnick L.S. Sadek M. Bjarnason H. Coleman D.M. Dillavou E.D. Hingorani A.P. et al.Classification and treatment of endothermal heat-induced thrombosis: recommendations from the American Venous Forum and the Society for Vascular Surgery.J Vasc Surg Venous Lymphat Disord. 2021; 9: 6-22Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar The second document was published in the May 2021 issue; it is entitled The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: A report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders, by Meissner and colleagues (Fig).12Meissner M.H. Khilnani N.M. Labropoulos N. Gasparis A.P. Gibson K. Greiner M. et al.The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: A report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders.J Vasc Surg Venous Lymphat Disord. 2021; 9: 568-584Abstract Full Text Full Text PDF PubMed Scopus (12) Google Scholar In a recent review of “ The Year's Best Venous Trials ” in VEIN Magazine, six of seven studies were published in JVS-VL.4Gagne P.J. Gasparis A. Black S. Thorpe P. Passman M. Vedantham S. et al.Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial.J Vasc Surg Venous Lymphat Disord. 2018; 6: 48-56.e1Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar,13Attaran R. The Year's Best Venous Trials [Online]. Veindirectory.org.https://www.veindirectory.org/magazine/issues/volume-14-issue-2/the-year-s-best-venous-trialsDate accessed: October 12, 2021Google Scholar, 14Brown C.S. Osborne N.H. Kim G.Y. Sutzko D.C. Wakefield T.W. Obi A.T. et al.Effect of concomitant deep venous reflux on truncal endovenous ablation outcomes in the Vascular Quality Initiative.J Vasc Surg Venous Lymphat Disord. 2021; 9: 361-368.e3Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar, 15Vähäaho S. Halmesmäki K. Mahmoud O. Albäck A. Noronen K. Venermo M. Three-year results of a randomized controlled trial comparing mechanochemical and thermal ablation in the treatment of insufficient great saphenous veins.J Vasc Surg Venous Lymphat Disord. 2021; 9: 652-659Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar, 16Attaran R.R. Bhalla A. Mena-Hurtado C.I. Ochoa Chaar C.I. Correlation between great saphenous length of treatment zone and diameter with improvement in symptoms after ablation.J Vasc Surg Venous Lymphat Disord. 2021 Mar 9; (S2213-333X(21)00099-8)Google Scholar, 17Aurshina A. Cardella J. Sumpio B. Zhuo H. Zhang Y. Dardik A. et al.Location of reflux in the saphenous vein does not affect outcomes of vein ablation.J Vasc Surg Venous Lymphat Disord. 2021; 9: 932-937Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar, 18Jayaraj A. Powell T. Raju S. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction.J Vasc Surg Venous Lymphat Disord. 2021 Jun 5; (S2213-333X(21)00287-0)Google Scholar The progress JVS journals made was due to the outstanding manuscripts we published in 2021, written by authors from around the world, and we are grateful for these contributions (Table II).19Koleilat I. Galen B. Choinski K. Hatch A.N. Jones D.B. Billett H. et al.Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019.J Vasc Surg Venous Lymphat Disord. 2021; 9: 36-46Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar, 20Chang H. Rockman C.B. Jacobowitz G.R. Speranza G. Johnson W.S. Horowitz J.M. et al.Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.J Vasc Surg Venous Lymphat Disord. 2021; 9: 597-604Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar, 21Obi A.T. Barnes G.D. Napolitano L.M. Henke P.K. Wakefield T.W. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.J Vasc Surg Venous Lymphat Disord. 2021; 9: 23-35Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar, 22Cho E.S. McClelland P.H. Cheng O. Kim Y. Hu J. Zenilman M.E. et al.Utility of d-dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infection.J Vasc Surg Venous Lymphat Disord. 2021; 9: 47-53Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar, 23Rali P. O'Corragain O. Oresanya L. Yu D. Sheriff O. Weiss R. et al.Incidence of venous thromboembolism in coronavirus disease 2019: an experience from a single large academic center.J Vasc Surg Venous Lymphat Disord. 2021; 9: 585-591.e2Abstract Full Text Full Text PDF PubMed Scopus (13) Google Scholar Success, however, would not have been achieved without the hard work and expertise of an exceptional JVS-VL editorial team. We greatly appreciate the contributions of our Associate Editors, Alan Dardik, Gregory L. Moneta, and Cynthia K. Shortell; and of our Assistant Editors, Ruth L. Bush, Paul DiMuzio, and Daniel K. Han. We also express our deepest gratitude to the dedicated members of our editorial board and our many reviewers, listed below, who have read, reviewed, and re-reviewed an increasing number of submissions. In recognition of a most successful year, we are pleased to extend the current positions of all our editors and editorial board members for the next 6 months. Thus, the new editorial leadership, who will start in July 2022, will have an opportunity to select new editors and editorial board members from the many outstanding individuals who wish to contribute to the JVS journals.Table IITop five most read articles published in JVS-VL in 202119Koleilat I. Galen B. Choinski K. Hatch A.N. Jones D.B. Billett H. et al.Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019.J Vasc Surg Venous Lymphat Disord. 2021; 9: 36-46Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar, 20Chang H. Rockman C.B. Jacobowitz G.R. Speranza G. Johnson W.S. Horowitz J.M. et al.Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.J Vasc Surg Venous Lymphat Disord. 2021; 9: 597-604Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar, 21Obi A.T. Barnes G.D. Napolitano L.M. Henke P.K. Wakefield T.W. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.J Vasc Surg Venous Lymphat Disord. 2021; 9: 23-35Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar, 22Cho E.S. McClelland P.H. Cheng O. Kim Y. Hu J. Zenilman M.E. et al.Utility of d-dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infection.J Vasc Surg Venous Lymphat Disord. 2021; 9: 47-53Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar, 23Rali P. O'Corragain O. Oresanya L. Yu D. Sheriff O. Weiss R. et al.Incidence of venous thromboembolism in coronavirus disease 2019: an experience from a single large academic center.J Vasc Surg Venous Lymphat Disord. 2021; 9: 585-591.e2Abstract Full Text Full Text PDF PubMed Scopus (13) Google ScholarTitleAuthorsVolumeIssueViews (all time)Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019Issam Koleilat, Benjamin Galen, Krystina Choinski, Ayesha Nzeribe Hatch, Davis Brent Jones, Henny Billett, Jeff Indes, Evan Lipsitz91124Deep vein thrombosis in hospitalized patients with coronavirus disease 2019Heepeel Chang, Caron B Rockman, Glenn R Jacobowitz, Giancarlo Speranza, William S Johnson, James M Horowitz, Karan Garg, Thomas S Maldonado, Mikel Sadek, Michael E Barfield93116Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infectionAndrea T Obi, Geoffrey D Barnes, Lena M Napolitano, Peter K Henke, Thomas W Wakefield91116Utility of d -dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infectionEdward S. Cho, MD, Paul H. McClelland, MD, Olivia Cheng, MD, Yuri Kim, MD, James Hu, MD,Michael E. Zenilman, MD, and Marcus D’Ayala, MD,9193Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic centerParth Rali, MD, Oisin O’Corragain, MB, BCh, BAO, Lawrence Oresanya, MD, Daohai Yu, PhD,Omar Sheriff, MD, Robert Weiss, MD, Catherine Myers, MD, Parag Desai, MD, Nadia Ali, MD,Anthony Stack, DO, Michael Bromberg, MD, PhD, Andrea L. Lubitz, MD, MPH, Joseph Panaro, MD,Riyaz Bashir, MD, Vladimir Lakhter, MD, Roberto Caricchio, MD, Rohit Gupta, MD,Chandra Dass, MBBS, DMRD,e Kumaran Maruti, MD, MBBS, FRCR, Xiaoning Lu, MS,A. Koneti Rao, MD, Gary Cohen, MD, Gerard J. Criner, MD, and Eric T. Choi, MD, for the Temple UniversityCOVID-19 Research Group,∗9380 Open table in a new tab Finally, we are particularly thankful to our dedicated JVS-VL staff, Senior Managing Editor Jessica McEwan, Managing Editors Alexandria Sese and Tyler Cosgrove, Senior Editorial Assistant Carlee Green, and Editorial Assistant Emily Sachs. We are also grateful to the Society for Vascular Surgery, the American Venous Forum, and our other sponsoring societies who support our journal and enable us to publish great articles from their annual meetings. As we welcome a new year in 2022, we continue to be thankful for the honor and the opportunity to serve you as editors of the great family of JVS Journals. We are extremely grateful for our expert reviewers for their valuable contributions. Peer reviewers work without compensation. They unselfishly provide their time and expertise to our journals. Peer review is essential to validate the credibility of scientific research by others working in the same field. The goal is to maintain the integrity of science, to improve the quality of the manuscripts, and provide valuable input to the editors who decide on the fate of the manuscripts. We are blessed to have excellent Associate and Assistant Editors who helped us in 2021 to manage the increasing number of submissions, without compromising the high quality of the articles published in JVS-VL. Drs Gregory Moneta and Cynthia Shortell served as Associate Editors for Clinical Studies and dealt with an overwhelming number of submissions this year. Dr Shortell also organized and handled a large number of systematic reviews and meta-analyses, so valuable to raise the quality of our journal. They were joined by Dr Ulka Sachdev-Ost, who reviewed both clinical and research papers, lead our efforts to improve diversity, equity and inclusion in our editorial system and directs the JVS internship program—great job by a dedicated surgeon. We are also thankful for the contributions of our Associate Editor for Basic Science, Dr Alan Dardik, who excels now in his new role as Editor of JVS-Vascular Science (JVS-VS). We are indebted to Dr Ruth Bush for her insightful commentaries and astute summaries of key non-JVS Publications on venous disease management in our Venous Vantage Point and for her book reviews. Special thanks to Dr Paul J. DiMuzio, Editor for Social Media, director of the JVS journal clubs and author of JVS Press Releases, and to Dr Daniel Han, who has become a master editor producing Visual Abstracts and helped us tremendously to increase our social media presence on Twitter, Facebook, LinkedIn and other platforms. We are thankful for the valuable contributions made by our excellent Editorial Board in 2021. In addition to the review and rereview of a large number of original articles, our editorial board members frequently contributed to JVS-VL with commentaries and editorials. Members of the Editorial Board performed an average of 5 reviews each year, and during 2021 this accounted for 52% of all the reviews performed. The Editors would like to recognize all board members, who will who continue their assignments in 2022. Jose Ignacio Almeida Pier Luigi Antignani Zachary M. Arthurs Faisal Aziz Iris Baumgartner Haraldur Bjarnason John Blebea Kellie R. Brown Patrick H. Carpentier Anthony J. Comerota Rachel Danczyk Jose Antonio Diaz Ellen Dillavou Sergio Gianesini Kathleen D. Gibson Manjit S. Gohel Linda Harris Nasim Hedayati Anil Hingorani Mark D. Iafrati Glenn R. Jacobowitz Arjun Jayaraj Manju Kalra Lois A. Killewich Pedro Pablo Komlós Nicos Labropoulos Byung-Boong Lee Marzia Lugli Fedor Lurie William A. Marston Elna M. Masuda Nick Morrison Patrick Muck Thomas Noppeney Andrea Tara Obi Thomas F. O’Donnell Kathleen Ozsvath W. Michael Park Kurosh Parsi Marc A. Passman Amani Politano Lori Pounds Thomas M. Proebstle Alessandra Puggioni Joseph D. Raffetto Seshadri Raju Lars Rasmussen Pauline Raymond-Martimbeau Michael J. Rohrer Sherry D. Scovell Evgeny V. Shaydakov Michael Stoner Julianne Stoughton Ramesh Kaushal Tripathi Jorge H. Ulloa Tomasz Urbanek André Van Rij Thomas W. Wakefield Jinsong Wang Jonathan Weiswasser Mark S. Whiteley Cees H. A. Wittens The Editors would like to recognize the Distinguished Reviewers of the Journal of Vascular Surgery Venous and Lymphatic Disorders, who have performed more than five reviews during the review period between January and September 2021, and who consistently performed the highest-rated and timely reviews. Distinguished Reviewers contributed 16% of all reviews. We thank them for their efforts to assure a high-quality peer-review process. Ruth L. Bush Michael C. Dalsing Matthew J. Eagleton G. Matthew Longo Robert B. Patterson Lewis B.Schwartz Michael J. Singh Kush Desai Anahita Dua Yana Etkin Naiem Nassiri Leigh Ann O'Banion Alvaro Orrego Britt H. Tonnessen The Editors are grateful to many clinicians and scientists who performed at least one review for the Journal during 2021. This group includes several New Reviewers. These reviewers performed 30% of all reviews and contributed greatly to our peer-review process. We would like to express our gratitude to them and look forward to working with them and with many more new reviewers in 2022. Lori Choi R. Clement Darling III Javairiah Fatima Spencer Galt David L. Gillespie Randolph P. Guzman Gregory J. Landry Evan C. Lipsitz Ying Wei Lum Robert A. McCready Gregory L. Moneta Nicholas Morrissey Stuart I. Myers David G. Neschis Lakshmikumar Pillai Joseph R. Schneider Amir Aazarbal Anton Dias Perera Monika Lecomte Gloviczki Houman Jalaie Melissa Loja Mohammad Hassan Murad Cassius Iyad Ochoa Chaar Danielle Marie Pineda Jean Marie Ruddy Mikel Sadek Shant M. Vartanian Suresh Vedantham Nikolaos Zacharias Vincent L. Rowe Dobrin Vassilev Trissa Babrowski Philip D. Coleridge-Smith Darwin Eton Hugh Gelabert Peter K. Henke Vikram S. Kashyap Timothy K. Liem Albeir Mousa David Andrew Rigberg Caron B. Rockman Daniel S. Rush Niten Singh Matthew R. Smeds Guilherme Yazbek Paolo Zamboni Leo J Daab Issam Koleilat Thanila Macedo Sebastian Mafeld Colleen Moore Juan Carlos Jimenez James Laredo Cynthia K. Shortell Christopher Audu Keith D. Calligaro Jerry C Chen David L. Dawson Audra A. Duncan Paul J. Gagne Thomas G. Lynch Eberhard Rabe Gerald S. Treiman Daniel B. Walsh Olamide Alabi Karem Harth Bernardo Mendes Jeniann Yi Lowell Stuart Kabnick Judith C Lin Gian Franco Veraldi Dean A. Healy Glenn C. Hunter Karl A. Illig Frank T. Padberg Jr MD John J. Ricotta Shawn Sarin Jovan Markovic Eleftherios S. Xenos E. John Harris Sharon C Kiang J. Gregory Modrall Finally, the Editors thank our statistical reviewers, who performed more than 70 reviews in 2021. Richard Amdur William Scott Harmsen Jay Mandrekar Edward Joseph Mascha Charles Miller We also would like to recognize our JVS Interns, who have already contributed to our journals with numerous excellent reviews. They are our future ambassadors, reviewers and editors. We are thankful for their interest in JVS and for their hard work as our reviewers. We list them below together with their JVS Mentors.Tabled 1InternMentorJessica M. MayorPaul DiMuzioAkiko TanakaKeith CalligaroAnand BrahmandamUlka SachdevShernaz S. DossabhoyThomas ForbesLaura M. DrudiAudra DuncanChristopher AuduAlan DardikElizabeth L. ChouGale Tang Open table in a new tab

Referência(s)